Platform that reduces the production costs of viral vectors for gene therapies.
| Date | Round | Amount |
|---|---|---|
| Feb 2026 | Funding round UK-based Tozaro raised £6 million led by Mercia Ventures to slash gene therapy manufacturing costs. | $8.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.